Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Ifosfamide in First-Line Metastatic Breast Cancer
NCT00026078Phase 2Unknown
- Sponsor
- Grupo Oncológico Cooperativo del Sur
- Start
- Mar 2001
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of docetaxel and ifosfamide in breast cancer, sponsored by Grupo Oncológico Cooperativo del Sur. Primary endpoint: Response Rate. Status: unknown.
02
Drugs
docetaxelifosfamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00026078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00026078.